BGCP
LLY icon

Bristol Gate Capital Partners’s Eli Lilly LLY Stock Holding History

Bristol Gate Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.5M Sell
75,612
-4,966
-6% -$5.03M 4.48% 10
2025
Q4 		$86.6M Sell
80,578
-13,262
-14% -$12.7M 5% 2
2025
Q3 		$71.6M Sell
93,840
-3,023
-3% -$2.25M 4.23% 15
2025
Q2 		$75.5M Sell
96,863
-21,412
-18% -$16.6M 4.29% 14
2025
Q1 		$97.7M Buy
+118,275
New +$98.4M 4.77% 8

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bristol Gate Capital Partners's LLY Position: Q1 2026 in Review

Bristol Gate Capital Partners reduced its Eli Lilly (LLY) stake by 6.2% in Q1 2026, selling an estimated $5.03M and leaving 75,612 shares worth $69.5M. The position accounts for 4.48% of the portfolio, ranked #10.

Bristol Gate Capital Partners first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $97.7M in Q1 2025. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bristol Gate Capital Partners held 75,612 shares of Eli Lilly worth $69.5M as of Q1 2026.
  • Bristol Gate Capital Partners sold 4,966 Eli Lilly shares in Q1 2026, an estimated $5.03M.
  • Eli Lilly made up 4.48% of Bristol Gate Capital Partners's portfolio in Q1 2026, its #10 holding.
  • Bristol Gate Capital Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Bristol Gate Capital Partners's Eli Lilly position peaked at $97.7M in Q1 2025.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bristol Gate Capital Partners's 13F filing for Q1 2026, filed 12 May 2026.